Hercules BDC (HTGC) $13, to Present at FB Riley.
Hercules Capital to Discuss 2019 Growth Opportunities at the B. Riley FBR Institutional Investor Conference
PALO ALTO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the...
Innovus (INNV) in Silicon Review Interview.
POISED FOR INNOVATION.
The Silicon Review is the world’s most trusted online and print community for business & technology professionals. Our community members include thought-provoking...
Innovus (INNV) Conference Call Transcript.
Q1 2019 Results, 5/15/19.
Innovus Pharmaceuticals, Inc. (OTCQB:INNV) Q1 2019 Earnings Conference Call May 15, 2019 4:15 PM ET
Company Participants
Bassam Damaj - President and CEO
Ryan...
Vaccinex (VCNX) Reports First Quarter 2019 Financial Results and Provides Corporate Update.
Updated interim data from CLASSICAL-Lung study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in June 2019
Enrollment...
Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.
The Company will host a conference call on Wednesday, May 15, 2019 at 4:15 p.m. ET/1:15 p.m. PT to discuss the financial results and...
Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)
(Originally published 4/25/2018)
“I am very steady. I like to work slowly, but surely, to get to my goal.” Thus speaks Bassam Damaj, president and...
Adding Innovus Pharma (INNV) $2.50 to Watch List.
Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its lineup.
We're adding...
Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!
Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current therapeutic conventions....
Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.
CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided...
Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.
Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women.
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or...
Latest article
Fairchild Gold (FAIR.V) Advances Towards Drilling.
Fairchild Gold Advances Toward Drilling at Nevada Titan as Geophysics Sharpens Porphyry Targeting
Vancouver, British Columbia and Las Vegas, Nevada--(Newsfile Corp. - August 21, 2026)...
Hecla Mining (HL) $20.75 – Rips 33% Higher, on Incredible Numbers.
Shareholders Celebrate $4 Billion Gain in Market Value, in a Couple Weeks! And we'll drink to that!
When we added Hecla Mining (HL) to the...
A Turnaround at Mitesco Coming? Mitesco Moves Into Mini-Data Centers.
Last Round (turnaround that is) worked great, back in 2019, Trading From $0.02 to $0.50. And no, we Didn't Sell a Single Share (waa)....
